MDRNA Inc. (MRNA) said its technology significantly reduced tumor growth in models of liver and bladder cancer. Shares jumped 20.2% premarket to...
Support
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads